with increasing concentrations (0-5μg/ml) of TM for 24 h. B) Cell viability as detected by MTT assay; C) percentage of apoptotic cells as detected by PI staining and FACS analysis; D) clonogenic assay, in the presence of 5μg/ml TM; E) ROS levels as detected by DCFH fluorescence. F) SEC16 expression in PC3 and MDAPCa2b cells, as determined by qPCR. Expression was normalised to GAPDH and reported as 2 − ΔΔCt . Relative mRNA level of untreated cells was assumed to be 1. *p < 0.05 vs. control cells. 
